InsidersTradesSigma
Discover the complete record of transactions filed by Sofia Heigis, 首席执行官. Officer active across 2 companies, notably Oncopeptides AB. Cumulatively, 1 disclosures have been recorded. History available since 17 March 2026. The latest transaction was filed on 17 March 2026 (Purchase). Regulator: FIN-FSA. The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 条申报中的 1 条
Sofia Heigis is the CEO of Oncopeptides AB. She is responsible for the strategic and operational direction of the company, ensuring its development and performance in the market.